Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck
Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck
复制标题
DOI：
10.1080/02841850410001268
复制
发表时间：
2004-11-01
期刊：
影响因子：
1.3
通讯作者：
Keski-Nisula, L
中科院分区：
文献类型：
--
作者：
Rautio, R;Laranne, J;Keski-Nisula, L
目的：为了评估血管内硬化治疗的长期结果静脉和静脉毛细血管畸形的面颈部region.Material和方法：20例连续endovascularly治疗静脉和毛细血管静脉畸形的面颈部被邀请参加临床控制和磁共振（MR）成像，并评估治疗后的生活质量。为了评估治疗后的生活质量，患者被要求填写一份问卷，其中包括20个多项选择题探索4个维度：心理，身体和社会功能，和pain.Results：在14例患者中，症状和MR结果改善，而在6例患者没有改善。关于生活质量的结果显示，大多数患者在血管内治疗后表现良好。舌静脉畸形的患者预后更差。年龄在16岁以下的患者在治疗开始和患者的临床随访的专业医生在血管畸形有更好的生活质量。结论：血管内治疗静脉畸形是有效的。结果和生活质量被证明是更好的血管内治疗开始之前，青春期和患者有定期的临床控制治疗后。
Purpose: To evaluate the long-term results of endovascular sclerotherapy in treating venous and venocapillary malformations of the face and neck region, and to assess the quality of life after treatment.Material and Methods: Twenty consecutive patients with endovascularly treated venous and capillary-venous malformation of the face and neck were invited to attend for clinical control and magnetic resonance (MR) imaging. To evaluate the quality of life after treatment, patients were asked to fill in a questionnaire which included 20 multiple-choice questions exploring 4 dimensions: psychological, physical, and social functioning, and pain.Results: In 14 patients, symptoms and MR findings improved, while in 6 patients there was no improvement. Results concerning quality of life showed that most patients did well after endovascular treatment. Patients with venous malformations of the tongue had a worse outcome. Patients under the age of 16 at the beginning of the treatment and patients clinically followed by physicians specialized in vascular malformations had a better quality of life.Conclusion: Endovascular treatment for venous malformations is effective. Results and quality of life proved to be better when the endovascular treatment was begun before puberty and the patients had regular clinical controls after therapy.